| ALRN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ALRN shares outstanding history going back to 6/29/2017:
Also see: ALRN Market Cap History ALRN YTD Return |
ALRN Shares Outstanding History — Aileron Therapeutics Share Count Over Time
As of 11/12/2024 Aileron Therapeutics has 21.67 million ALRN shares outstanding. Investors often track the ALRN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ALRN share count trends over time, with 31 historical shares outstanding datapoints presented, dating back to 6/29/2017.
| ALRN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ALRN Historical Shares Outstanding: +58.17% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ALRN Stock Price Chart |
| About Rein Therapeutics Inc |
| Aileron Therapeutics, Inc. is a biopharmaceutical company. Co. is advancing a pipeline of medicines to address unmet medical needs in orphan pulmonary and fibrosis indications. Its lead product candidate, LTI-03, is a synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. LTI-03 is being evaluated in a Phase Ib clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its second product candidate, LTI-01, is a proenzyme, or zymogen, designed to slowly activate in the pleural space and break up the scar tissue, allowing for drainage of the pleural effusion. We show 31 historical shares outstanding datapoints in our coverage of ALRN's shares outstanding history. Understanding the changing numbers of ALRN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ALRN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ALRN by allowing them to research ALRN shares outstanding history as well as any other stock in our coverage universe. |
| ALRN Current Stock Quote |
Quotes delayed 20 minutes  Free ALRN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ALRN Share Performance |
| Shares Outstanding Peers |
| Aileron Therapeutics (ALRN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ALT Shares Outstanding History ALTS Shares Outstanding History ALUR Shares Outstanding History ALVR Shares Outstanding History ALXN Shares Outstanding History ALXO Shares Outstanding History ALZN Shares Outstanding History AMAG Shares Outstanding History AMAM Shares Outstanding History AMDA Shares Outstanding History More Healthcare companies » |
ALRN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
